Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Centre for Addiction and Mental Health | OTHER |
| University of Toronto | OTHER |
Not provided
Not provided
Not provided
This study will evaluate the feasibility of repetitive Transcranial Magnetic Stimulation (rTMS) in Autism Spectrum Disorder (ASD) with self-regulation impairment. Baseline and follow-up participant visits will include behavioral assessments of self-regulation and magnetic resonance imaging (MRI) to determine neurophysiological outcomes before and after rTMS treatment.
Children and youth with Autism Spectrum Disorder (ASD) often present with co-morbid impairments in self-regulation (e.g., difficulty managing their emotions) resulting in unhelpful regulatory approaches such as disruptive compulsive, aggressive and self-injurious behaviour. There is an urgent need to establish novel, precise and effective interventions that promote self-regulation and reduce disruptive behaviours. This project will collect pilot data on the effects of repetitive TMS in reducing disruptive behaviours in youth with ASD, in order to inform the design of a follow-up full-scale clinical trial. Youth with ASD who experience clinically significant difficulties with self-regulation and disruptive behaviour will be recruited. Participants will be randomized to rTMS or sham rTMS for 3 weeks. The overall feasibility of the trial will be assessed. The effect of rTMS on the brain mechanisms of self-regulation and clinical improvement in disruptive behaviours will also be measured. Neurophysiological outcomes, including changes in regional brain network activity for inhibition of behaviour, will be explored.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| repetitive transcranial magnetic stimulation (rTMS) | Experimental | Participants will receive 15 rTMS sessions for 3 weeks. |
|
| Sham | Sham Comparator | Participants will receive 15 sessions of sham stimulation for 3 weeks. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| repetitive transcranial magnetic stimulation (rTMS) | Device | 30 minutes rTMS session 5 days/week for 3 weeks. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Recruitment | Recruitment rates of 4 participants/month are achieved with a ≥ 20% response rate | Weeks 1-18 |
| Attrition | Attrition rates of less than 10% (i.e., ≥90% of participants successfully complete assessments). | Weeks 1-18 |
| Adherence | 90% of participants who complete assessment achieve the target intensity and dose (15 rTMS sessions) | Weeks 1-18 |
| Blinding success | Blinding of participants and their parents/caregivers and required study team members will be assessed using a Blinding Questionnaire indicating the perceived group membership (rTMS/sham) | Weeks 1-18 |
| Measure | Description | Time Frame |
|---|---|---|
| Clinical Measure of Self-regulation: Emotion Dysregulation Index Reactivity and Dysphoria | Change in total score on Reactivity (0-96) and Dysphoria (0-24) scales - greater scores indicates a worse outcome | Weeks 1, 6, 18 |
| Clinical Measure of Self-Regulation: The Response To Stress Questionnaire - Family Stress |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Deryk Beal, PhD | Contact | 416-425-6220 | 3582 | dbeal@hollandbloorview.ca |
| Name | Affiliation | Role |
|---|---|---|
| Deryk Beal, PhD | Holland Bloorview Research Institute | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Bloorivew Research Institute | Recruiting | Toronto | Ontario | M4G 1R8 | Canada |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 26536383 | Background | Oberman LM, Enticott PG, Casanova MF, Rotenberg A, Pascual-Leone A, McCracken JT; TMS in ASD Consensus Group. Transcranial magnetic stimulation in autism spectrum disorder: Challenges, promise, and roadmap for future research. Autism Res. 2016 Feb;9(2):184-203. doi: 10.1002/aur.1567. Epub 2015 Nov 4. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000067877 | Autism Spectrum Disorder |
| D000080103 | Emotional Regulation |
| ID | Term |
|---|---|
| D002659 | Child Development Disorders, Pervasive |
| D065886 | Neurodevelopmental Disorders |
| D001523 | Mental Disorders |
| D000068356 | Self-Control |
Not provided
Not provided
| ID | Term |
|---|---|
| D050781 | Transcranial Magnetic Stimulation |
| ID | Term |
|---|---|
| D055909 | Magnetic Field Therapy |
| D013812 | Therapeutics |
Not provided
Not provided
Randomized sham-controlled rTMS trial
Not provided
Not provided
Participants and outcomes assessor will be blind to rTMS or sham condition.
| Sham stimulation | Other | 30 minutes sham stimulation 5 days/week for 3 weeks. |
|
Change in total score Response To Stress Questionnaire Family Stress Version (57-228, greater score indicates worse a outcome) |
| Weeks 1, 6, 18 |
| Clinical Measure of Self-regulation: Aberrant Behaviour Checklist - Irritability Subscale | Change in total score on Aberrant Behaviour Checklist - Irritability Subscale (15-60, greater score indicates a worse outcome) | Weeks 1, 6, 18 |
| Clinical Measure of Self-regulation: Emotional Regulation Checklist | change in total score on Emotional Regulation Checklist (24-96, low scores indicate worse outcomes) | Weeks 1, 6, 18 |
| Overall Clinical Change | Clinical Global Impression scale - 1 item on a scale from 0-7 (a change of 0.5 indicates a clinical impact of significance) | Weeks 1, 6, 18 |
| Inhibitory control | Go/No-Go Task Performance | Weeks 1, 6, 18 |
| Functional brain changes (magnetic resonance imaging) | change in blood oxygen level dependent (BOLD) signal associated with go/no-go task | Weeks 1, 6, 18 |
| Structural brain changes (magnetic resonance imaging) | Diffusion imaging - change in fractional anisotropy | Weeks 1, 6, 18 |
| D012919 | Social Behavior |
| D001519 | Behavior |